DEUTSCHE BANK AG\
BankPosition in PRTA — Prothena Corp Public Ltd Co
CIK 948046
FRANKFURT AM MAIN, 2M
Position in PRTA
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$423,613
+$34,639 QoQ
Shares Held
43,270
+8.1% QoQ
Ownership
0.084%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#71
of 187 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in PRTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026DEUTSCHE BANK AG\ holds $3,190,028,280 across 296 Biotechnology names. PRTA ranks #187 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,579,110 | $784,391,303 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
518,409 | $323,248,743 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
815,400 | $245,459,858 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
888,019 | $166,308,196 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,717,951 | $152,395,510 | |
| 6 | INCY |
Incyte Corp
|
1,262,988 | $143,172,312 | |
| 7 | ARGX |
Argenx SE
|
137,335 | $127,415,291 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
249,611 | $78,899,539 |
All Filings in PRTA
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $423,613 | 43,270 | Shares | Defined | 2026-08-07 | |
| 2026-03-31 | $388,974 | 40,018 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $338,852 | 35,482 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $329,624 | 33,773 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $240,377 | 39,601 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $1,185,647 | 95,810 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $1,329,183 | 95,970 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $543,021 | 32,458 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $568,714 | 27,554 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $790,087 | 31,897 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $806,783 | 22,201 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,091,076 | 22,613 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $1,348,939 | 19,756 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,325,702 | 27,351 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,319,354 | 21,898 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $986,995 | 16,279 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $539,551 | 19,873 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $817,118 | 22,344 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,216,424 | 24,624 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $2,254,285 | 31,648 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $1,111,072 | 21,612 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $502,852 | 20,018 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $328,844 | 27,381 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $341,937 | 34,228 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $716,927 | 68,540 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $836,642 | 78,191 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||